• Return to Headlines

Pozen has the Lowest Free Cash Flow Per Share in the Pharmaceuticals Industry (POZN, AKRX, IPXL, CPIX, SCLN)

By James Quinn

Below are the three companies in the Pharmaceuticals industry with the lowest (positive) free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.

Pozen ranks lowest with a FCF per share of $0.01. Akorn is next with a FCF per share of $0.01. Impax Laboratories ranks third lowest with a FCF per share of $0.04.

Cumberland Pharmaceuticals follows with a FCF per share of $0.37, and Sciclone Pharmaceuticals rounds out the bottom five with a FCF per share of $0.51.

SmarTrend recommended that subscribers consider buying shares of Sciclone Pharmaceuticals on November 9th, 2015 as our technology indicated a new Uptrend was in progress when shares hit $7.98. Since that recommendation, shares of Sciclone Pharmaceuticals have risen 84.2%. We continue to monitor Sciclone Pharmaceuticals for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest free cash flow per share pozen akorn impax laboratories cumberland pharmaceuticals sciclone pharmaceuticals